UK Companies House feature
TEVA UK LIMITED
Profile
- Company number
- 00302461
- Status
- Active
- Incorporation
- 1935-07-01
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Future forecasts show that credit facilities are not required in order for Teva UK Limited to continue as a going concern however, the directors have obtained a letter of support from Teva Pharmaceuticals B.V. in the event that additional financial support should become necessary.”
Significant events
- “On 5 November 2024, Teva UK Holdings Limited transferred the entire shareholdings of its subsidiary companies, which included that of Teva UK Limited, to Teva Pharma Holdings Limited by way of a dividend in specie. With effect from this date, the Teva Pharma Holdings Limited became the company's immediate holding company.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
2 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHARLESWORTH, Stephen Michael | Director | 2020-04-29 | Feb 1967 | British |
| INNES, Kim | Director | 2016-09-27 | Aug 1968 | British |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HARRIS, Michael John | Secretary | — | 1996-07-24 |
| GRAYS INN SECRETARIES LIMITED | Corporate Secretary | 1996-07-24 | 2010-04-14 |
| PINSENT MASONS SECRETARIAL LIMITED | Corporate Secretary | 2017-03-13 | 2017-03-13 |
| ALLINGTON, Timothy James | Director | — | 1996-07-24 |
| ANDRIESSEN, Theo Jacobus | Director | 1997-12-16 | 2012-10-26 |
| BEIGHTON, John | Director | 2002-10-31 | 2009-09-02 |
| BHATTACHARJEE, Dipankar | Director | 2009-09-02 | 2011-11-16 |
| BLINMAN, Peter | Director | 1994-04-29 | 1996-07-24 |
| COOPER, Dean Michael | Director | 2018-07-12 | 2020-04-29 |
| DANIELL, Richard Gordon | Director | 2016-03-18 | 2016-09-27 |
| DANIELL, Richard Gordon | Director | 2011-11-16 | 2015-08-03 |
| HARRIS, Michael John | Director | 1994-04-29 | 1996-07-24 |
| HORSMAN, Peter | Director | 1997-12-16 | 2009-03-04 |
| HURVITZ, Chaim | Director | 1996-07-24 | 2002-10-31 |
| HURVITZ, Eliahu | Director | 1996-07-24 | 2002-04-30 |
| KAY, Andrew George | Director | 1994-11-01 | 2002-10-31 |
| KOREMANS, Robert | Director | 2012-10-19 | 2014-03-31 |
| MAKOV, Israel | Director | 1996-07-24 | 2002-11-07 |
| MANN, Meron | Director | 2002-10-31 | 2006-02-01 |
| MICHELMORE, John Douglas | Director | — | 1996-02-27 |
| NOORDERMEER, Gertjan | Director | 2014-03-31 | 2014-09-09 |
| OLDFIELD, Stephen Philip | Director | 2015-08-03 | 2016-03-18 |
| ORESKOVIC, Tim | Director | 2014-09-09 | 2016-01-14 |
| SCHREWE, Michael | Director | 2013-03-21 | 2016-08-01 |
| STANTON, Frances Louise | Director | — | 1994-04-29 |
| STOCKS, Steven | Director | — | 1994-03-31 |
| VRHOVEC, David | Director | 2016-05-01 | 2026-01-01 |
| WILLIAMS, Robert | Director | 2016-03-18 | 2018-06-27 |
| WILLIAMS, Robert | Director | 2009-03-04 | 2013-03-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Teva Pharma Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2024-11-05 | Active |
| Teva Uk Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2024-11-05 |
Filing timeline
Last 20 of 246 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-01-19 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-01-05 | TM01 | officers | termination director company with name termination date |
| 2025-09-26 | AA | accounts | accounts with accounts type full |
| 2025-02-10 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-02-10 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-02-10 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2024-10-09 | AA | accounts | accounts with accounts type full |
| 2024-01-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-09-22 | AA | accounts | accounts with accounts type full |
| 2023-01-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-10-07 | AA | accounts | accounts with accounts type full |
| 2022-01-20 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-10-03 | AA | accounts | accounts with accounts type full |
| 2021-04-15 | CH01 | officers | change person director company with change date |
| 2021-03-30 | CH01 | officers | change person director company with change date |
| 2021-02-02 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2020-11-09 | AA | accounts | accounts with accounts type full |
| 2020-10-13 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-10-12 | CS01 | confirmation-statement | confirmation statement with updates |
| 2020-04-29 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.